Acyclovir ophth oint 3percent wobliquev,Ciprofloxacin HCL 0point3percent PLUS Dexamethasone 0point1
Armed Forces Tribunal
BARAMULLA, JAMMU & KASHMIR
Bid Publish Date
26-May-2025, 4:52 pm
Bid End Date
25-Jun-2025, 5:00 pm
Value
₹33,947
Location
Progress
RAQuantity
9840
Bid Type
Two Packet Bid
Indian Army invites bids for Acyclovir Ophth Ointment 3 ww in 5gm, Timolol Maleate 0. 5 Preservative free with Comod System, Ciprofloxacin HCI 0. 3 Tube of 5gm, Sodium Chloride Eye Drops 5 5ml Bott, Olopatadine 0. 2 Ophthalmic Soln Bott of 5ml, Alprazolam 0. 25 mg Tab, Ipratropium Bromide Respirator Soln 500mcg 2ml Respule, Dextrose 50 25 ml Inj, Dextrose Inj 25 25 ml Inj, Colchicine 0. 5 mg Tab, Cefotaxime Sodium 1gm Inj, Ranolazine 500 mg Tab in CENTRAL DELHI, DELHI. Quantity: 9840. Submission Deadline: 25-06-2025 17: 00: 00. Submit your proposal before the deadline.
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Armed Forces Tribunal
BARAMULLA, JAMMU & KASHMIR
Indian Army
HYDERABAD, TELANGANA
Indian Army
JALPAIGURI, WEST BENGAL
Indian Army
Indian Army
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Acyclovir Ophth Ointment 3 ww in 5gm | Acyclovir Ophth Ointment 3 ww in 5gm | 180 | tube | [email protected] | 15 |
| 2 | Timolol Maleate 0.5 Preservative free with Comod System | Timolol Maleate 0.5 Preservative free with Comod System | 240 | vial | [email protected] | 15 |
| 3 | Ciprofloxacin HCI 0.3 Tube of 5gm | Ciprofloxacin HCI 0.3 Tube of 5gm | 120 | tube | [email protected] | 15 |
| 4 | Sodium Chloride Eye Drops 5 5ml Bott | Sodium Chloride Eye Drops 5 5ml Bott | 120 | bott | [email protected] | 15 |
| 5 | Olopatadine 0.2 Ophthalmic Soln Bott of 5ml | Olopatadine 0.2 Ophthalmic Soln Bott of 5ml | 1,200 | bott | [email protected] | 15 |
| 6 | Alprazolam 0.25 mg Tab | Alprazolam 0.25 mg Tab | 5,280 | no | [email protected] | 15 |
| 7 | Ipratropium Bromide Respirator Soln 500mcg 2ml Respule | Ipratropium Bromide Respirator Soln 500mcg 2ml Respule | 480 | no | [email protected] | 15 |
| 8 | Dextrose 50 25 ml Inj | Dextrose 50 25 ml Inj | 30 | vial | [email protected] | 15 |
| 9 | Dextrose Inj 25 25 ml Inj | Dextrose Inj 25 25 ml Inj | 30 | vial | [email protected] | 15 |
| 10 | Colchicine 0.5 mg Tab | Colchicine 0.5 mg Tab | 600 | no | [email protected] | 15 |
| 11 | Cefotaxime Sodium 1gm Inj | Cefotaxime Sodium 1gm Inj | 60 | vial | [email protected] | 15 |
| 12 | Ranolazine 500 mg Tab | Ranolazine 500 mg Tab | 1,500 | no | [email protected] | 15 |
Discover companies most likely to bid on this tender
Start
08-Jul-2025, 11:00 am
End
16-Jul-2025, 9:00 am
Duration: 190 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Key insights about DELHI tender market
The eligibility requirements include being a registered entity with the necessary compliance credentials to supply pharmaceutical products. Bidders must demonstrate their capability through relevant certifications, adherence to quality standards, and a proven track record in delivering similar products.
Bidders must adhere to strict technical specifications outlined in the tender document. This includes compliance with national and international pharmaceutical standards, ensuring that all products are produced in certified facilities that follow Good Manufacturing Practices (GMP). Compliance documentation should be included in all submissions.
The EMD is a financial security measure that bidders must submit along with their proposals. It demonstrates commitment to the process and safeguards against non-compliance with the tender terms. The EMD will be forfeited if the selected bidder fails to comply with the contract terms post-award.
Bids for this tender must be electronically submitted via the GEM e-procurement platform. It's crucial that all required documentation is completed and formatted as per the tender guidelines to ensure compliance and successful submission.
The tender includes special provisions aimed at benefiting Micro, Small, and Medium Enterprises (MSEs), which may involve relaxed eligibility criteria, access to financial support, and prioritized evaluation. These benefits are designed to foster participation from smaller entities and enhance competition in the procurement process.
By adhering to these structured guidelines and requirements, interested parties can maximize their chances of success in this tender opportunity.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS